3850-43-9

Basic information

• Product Name: N-[3-(4-hydroxy-phenyl)-propionyl]-glycine
• Synonyms: N-[3-(4-hydroxy-phenyl)-propionyl]-glycine
• CAS NO: 3850-43-9
• Molecular Weight: 223.229
• Mol File: 3850-43-9.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: N-[3-(4-hydroxy-phenyl)-propionyl]-glycine(CAS DataBase Reference)
• NIST Chemistry Reference: N-[3-(4-hydroxy-phenyl)-propionyl]-glycine(3850-43-9)
• EPA Substance Registry System: N-[3-(4-hydroxy-phenyl)-propionyl]-glycine(3850-43-9)

Safety Data

• Hazardous Substances Data: 3850-43-9(Hazardous Substances Data)

Upstream product

• 501-97-3 4-hydroxyphenylpropionic acid 
• 459-73-4 GlyOEt*HCl 
• 7400-08-0 p-Coumaric Acid 
• 134447-09-9 3-(-4-methoxycarbonyloxyphenyl)propionic acid 
• 160538-48-7 [3-(4-Hydroxy-phenyl)-propionylamino]-acetic acid benzyl ester 
• 861565-55-1 3-(4-methoxycarbonyloxy-phenyl)-propionyl chloride 
• 56-40-6 glycine 

Downstream Products

• 160538-49-8 N-[(3-Fluoro-4-nitro-benzylcarbamoyl)-methyl]-3-(4-hydroxy-phenyl)-propionamide 

Relevant articles and documents

Studies Directed Towards the Total Synthesis of Vancomycin: Formation of Biphenyl Ether by Macrocyclisation

A simple methodology for the construction of D-O-E diphenyl ether 16-membered ring system present in Vancomycin by intramolecular displacement of fluorine by phenoxide reaction is described.

7-thiabicycloheptane substituted diamide and its congener prostaglandin analogs

7-Thiabicycloheptane substituted diamide and congener prostaglandin analogs are provided having the structural formula STR1 wherein m is 1 to 4; A is --CH=CH-- or --CH2 --CH2 --; n is 1 to 5; R is CO2 H, CO2 alkyl, CO2 alkali metal, CO2 polyhydroxyamine salt, --CH2 OH, STR2 wherein R3 and R4 are the same or different and are H, lower alkyl, hydroxy, lower alkoxy or aryl, at least one of R3 and R4 being other than hydroxy and lower alkoxy; p is 1 to 4; Z is STR3 q is 1 to 12; R1 is H or lower alkyl; and R3 is H, lower alkyl, lower alkenyl, lower alkynyl, aryl, arylalkyl, lower alkoxy, aryloxy, arylalkyloxy, amino, alkylamino arylamino, arylalkylamino, STR4 (wherein n' is 0, 1 or 2), alkylaminoalkyl, arylaminoalkyl, arylalkylaminoalkyl, alkoxyalkyl, aryloxyalkyl or arylalkoxyalkyl. The compounds are cardiovascular agents useful, for example, in the treatment of thrombotic disease.

Bisthioamide-7-oxabicycloheptane prostaglandin analogs

Bisthioamide-7-oxabicycloheptane prostaglandin analogs are provided having the structural formula STR1 wherein A is --CH=CH-- or --CH2 --CH2 --; n is 1 to 5; R is CO2 H, CO2 lower alkyl or STR2 q is 1 to 12; and R1 is H, lower alkyl, lower alkenyl, lower alkynyl, aryl, arylalkyl, lower alkoxy, aryloxy, arylalkyloxy, amino, alkylamino arylamino, arylalkylamino, lower alkyl-S-aryl-S-, arylalkyl-S-, STR3 (wherein n' is 0, 1 or 2), alkylaminoalkyl, arylaminoalkyl, arylalkylaminoalkyl, alkoxyalkyl, aryloxyalkyl or arylalkoxyalkyl. The compounds are cardiovascular agents useful, for example, in the treatment of thrombotic disease.